Page 14 of 32

OP10.4 | Vitamin A Deficiency: Ocular Manifestations, Management and Referral — SDL Guide (Part 3)

Indications for Referral and Prevention

Knowing when to refer and how to prevent recurrence are the two most consequential clinical decisions in managing vitamin A deficiency at the primary care level. The referral decision is driven entirely by whether the cornea is involved: stages XN and X1A/X1B affect only the conjunctiva and rod function, and these respond reliably to vitamin A supplementation administered at the PHC level without any specialist input. But once the cornea is involved — from stage X2 onwards — the clock is ticking on irreversible visual loss, and specialist ophthalmic assessment and management become mandatory. The reason is straightforward: corneal stromal damage and keratomalacia involve mechanisms (matrix metalloproteinase-driven collagen dissolution, secondary bacterial superinfection of the exposed stroma) that go beyond the restoration of vitamin A levels alone and may require topical antibiotics, lubricants, bandage contact lenses, or even surgical intervention (tarsoconjunctival flap, corneal grafting in late stages). Prevention, on the other hand, is an entirely PHC-level responsibility — the NPCBVI supplementation schedule, dietary counselling, and measles vitamin A co-administration can all be delivered by a nurse or ASHA worker without any ophthalmologist involvement. Understanding both sides of this threshold — treat early stages at PHC, refer all corneal stages urgently — defines safe practice.

Indications for referral to ophthalmology:
- Any stage X2 or above (corneal involvement): Corneal xerosis, keratomalacia (X3A, X3B), and corneal scarring (XS) require expert ophthalmic assessment and management. Keratomalacia at X3B in particular is a surgical emergency — corneal graft or keratoprosthesis may be considered once the acute phase resolves, but the prognosis for vision restoration is very poor.
- Stages XN and X1A/X1B: Primary care treatment with vitamin A supplementation is appropriate; routine ophthalmic review is desirable but not a same-day emergency if corneas are clear.
- Any child with reduced visual acuity beyond what would be expected from the current stage.

Prevention — India-specific programme:
India's National Programme for Control of Blindness and Visual Impairment (NPCBVI) includes a childhood vitamin A supplementation schedule as part of universal immunisation programme outreach:
- First dose: 100,000 IU at 6 months of age (with measles vaccine)
- Subsequent doses: 200,000 IU every 6 months from age 18 months to 5 years (administered by ANMs and ASHA workers during immunisation sessions)

This schedule, combined with dietary diversification campaigns and vitamin A food fortification (vanaspati, milk), has significantly reduced the prevalence of VAD in India, though pockets of high prevalence persist in tribal, remote, and flood-affected areas.

Community-level prevention strategies:
1. Dietary education: promote consumption of vitamin A-rich local foods (drumstick leaves, papaya, eggs, liver when available).
2. Kitchen gardens: promotion of growing beta-carotene-rich vegetables at household level.
3. Fortification: vitamin A fortification of cooking oil and milk (FSSAI mandated).
4. Supplementation: ensuring universal coverage of the NPCBVI childhood supplementation schedule.
5. Deworming: intestinal helminths compete for fat-soluble vitamins; deworming improves vitamin A absorption.

Self-Assessment: Xerophthalmia Staging and Management

Before leaving this SDL, verify that you can answer the following questions without referring back to the text. Xerophthalmia is one of the highest-yield topics in community ophthalmology for MBBS examinations precisely because it tests three domains simultaneously: biochemistry (the role of vitamin A in rhodopsin synthesis and mucosal differentiation), clinical medicine (staging, examination findings, treatment protocol), and public health (NPCBVI supplementation schedule, measles protocol, preventive strategies). The WHO staging system in particular is tested repeatedly in spot diagnoses, short answer questions, and viva examinations — students who have memorised the stages in the correct order, and who can correctly identify Bitot's spots as a conjunctival rather than a corneal lesion, consistently score full marks on this section. The six questions below cover the minimum safe-practice knowledge that every doctor working in India's primary care system must have memorised and immediately available — not because you will always have time to look things up, but because in the field, when a malnourished child with a foamy conjunctival deposit arrives at the PHC at 5 PM on a Friday, the treatment decision must be made immediately and correctly.

1. List the WHO xerophthalmia stages in order (XN → X1A → X1B → X2 → X3A → X3B → XS → XF).
2. What is X1B? Where are Bitot's spots located — on the conjunctiva or the cornea?
3. At which stage does corneal involvement begin (and therefore urgent referral is needed)?
4. What is the WHO treatment dose for a child aged 3 years with active xerophthalmia — and on which days?
5. Name three vitamin A-rich Indian food sources accessible to low-income families.
6. Which NPCBVI supplementation dose is given at age 6 months and what is the dose given every 6 months thereafter?

If you cannot answer questions 2, 3, and 4 without referring back, re-read the relevant sections. These are the minimum safe-practice knowledge requirements for any doctor practising in a district hospital or community setting in India.